Vr Adviser, LLC Viridian Therapeutics, Inc.\De Transaction History
Vr Adviser, LLC
- $912 Million
- Q2 2024
A detailed history of Vr Adviser, LLC transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Vr Adviser, LLC holds 3,882,671 shares of VRDN stock, worth $86.1 Million. This represents 5.54% of its overall portfolio holdings.
Number of Shares
3,882,671
Previous 3,882,671
-0.0%
Holding current value
$86.1 Million
Previous $68 Million
25.7%
% of portfolio
5.54%
Previous 5.84%
Shares
10 transactions
Others Institutions Holding VRDN
# of Institutions
151Shares Held
61.9MCall Options Held
133KPut Options Held
207K-
Black Rock Inc. New York, NY4.77MShares$106 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.92MShares$87 Million1.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.35MShares$74.2 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.31MShares$73.3 Million0.85% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.9MShares$64.2 Million1.52% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $884M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...